MPG.eBooks - Search Results

1

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma / drug therapy...”

Read Now

2

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma / drug therapy...”

Read Now

3

Pharmacoeconomic review report: Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on behalf of Icon Canada Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma, Open-Angle / drug therapy...”

Read Now

4

CADTH Canadian Drug Expert Committee recommendation: Travoprost 0.003% (Izba -- Novartis Pharmaceuticals Canada inc. on behalf of Alcon Canada Inc.) : indication : for the reductio...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma, Open-Angle / drug therapy...”

Read Now

5

Pharmacoeconomic review report: Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on behalf of Icon Canada Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma, Open-Angle / drug therapy...”

Read Now

6

Pharmacoeconomic review report: Preservative-free latanoprost 50 [mu]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)

Published 2018

CADTH

Subjects: “...Glaucoma, Open-Angle / drug therapy...”

Read Now

7

Pharmacoeconomic review report: Preservative-free latanoprost 50 [mu]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)

Published 2018

CADTH

Subjects: “...Glaucoma, Open-Angle / drug therapy...”

Read Now

8

Pharmacoeconomic review report: Cyclosporine (Verkazia) (Santen Canada inc.) : indication: treatment of severe vernal keratoconjunctivitis in children from four years of age throug...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“... disutility was also associated with glaucoma. Direct medical costs were estimated from Canadian sources...”

Read Now

9

Pharmacoeconomic review report: Cyclosporine (Verkazia) (Santen Canada inc.) : indication: treatment of severe vernal keratoconjunctivitis in children from four years of age throug...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“... disutility was also associated with glaucoma. Direct medical costs were estimated from Canadian sources...”

Narrow Search